Oramed Pharmaceuticals (ORMP) Receivables - Affiliates (2012 - 2014)
Oramed Pharmaceuticals (ORMP) posted Receivables - Affiliates of $523.0 for Q2 2014, down 69.45% on a QoQ basis from $1712.0 in Q1 2014, and down 29.89% year-over-year from $746.0 in Q2 2013.
Oramed Pharmaceuticals (ORMP) Receivables - Affiliates (2012 - 2014) Analysis & Trends
Oramed Pharmaceuticals' Receivables - Affiliates history runs 3 years deep, the most recent figure standing at $523.0 for Q2 2014.
- Quarterly Receivables - Affiliates fell 29.89% year-over-year to $523.0 in Q2 2014, while the trailing twelve-month figure through May 2014 was $523.0 (down 29.89% YoY) and the FY2013 annual result came in at $4530.0, up 1021.29% from the prior year.
- Receivables - Affiliates was $523.0 for Q2 2014 at Oramed Pharmaceuticals, down from $1712.0 in the prior quarter.
- Across five years, Receivables - Affiliates topped out at $5097.0 in Q4 2013 and bottomed at $404.0 in Q3 2012.
- A 3-year average of $2010.8 and a median of $1715.5 in 2012 frame the typical range for Receivables - Affiliates.
- Peak annual rise in Receivables - Affiliates reached 1021.29% in 2013, while the deepest fall reached 56.7% in 2013.
- Oramed Pharmaceuticals' Receivables - Affiliates stood at $1719.0 in 2012, then jumped by 196.51% to $5097.0 in 2013, then slumped by 89.74% to $523.0 in 2014.
- Business Quant data shows ORMP's Receivables - Affiliates at $523.0 in Q2 2014, $1712.0 in Q1 2014, and $5097.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Affiliates (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2014 | 523.00 |
| May 31, 2014 | 523.00 |
| Feb 28, 2014 | 1,712.00 |
| Feb 28, 2014 | 1,712.00 |
| Nov 30, 2013 | 5,097.00 |
| Nov 30, 2013 | 5,097.00 |
| Aug 31, 2013 | 4,530.00 |
| Aug 31, 2013 | 4,530.00 |
| May 31, 2013 | 746.00 |
| May 31, 2013 | 746.00 |
| Feb 28, 2013 | 3,222.00 |
| Feb 28, 2013 | 3,222.00 |
| Nov 30, 2012 | 1,719.00 |
| Nov 30, 2012 | 1,719.00 |
| Aug 31, 2012 | 404.00 |
| Aug 31, 2012 | 404.00 |
| May 31, 2012 | 1,723.00 |
| May 31, 2012 | 1,723.00 |
| Feb 29, 2012 | 432.00 |
| Feb 29, 2012 | 432.00 |